MyFinsight
Home
Blog
About
Contact
Download
Download image
Vendor advances, gross
$1,756K
Cash and cash
equivalents
$3,675K
Vendor advances, net
$625K
Prepaid expenses and
other current assets
$143K
Deferred offering costs
$1,279K
Intangible assets, net
$22K
Less accumulated
amortization
$1,131K
Total current assets
$4,443K
Total other assets
$1,301K
Total assets
$5,744K
Total liabilities and
shareholders equity
$5,744K
Total shareholders
equity
$5,313K
Total current
liabilities
$431K
Accumulated deficit
-$15,916K
Additional paid-in capital
$21,208K
Accounts payable and
accrued expenses
$431K
Common stock, par value
0.001, 100,000,000...
$21K
Back
Back
Balance Sheet
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)
source: myfinsight.com